• 0151 705 3400
  • info@cynapsedx.com

Neurodegenerative Disease – a problem caused by protein aggregation?


CynapseDx develops analytical technologies for the detection of aggregated protein biomarkers in the blood of people suffering from a neurodegenerative disease, such as Alzheimer's or Parkinson's Diseases.
The aim is to provide clinically useful information on the presence and the severity of the disease; allowing both general and personalised therapies to be employed.